Ironwood is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines targeting important therapeutic needs. Our goal is to build the next great pharmaceutical company—an outstanding business that will thrive and endure well beyond our lifetimes and generate substantial returns for our shareholders.

02.16.2010
Underwriters Exercise Over-Allotment Option for Ironwood Pharmaceuticals' Initial Public Offering

11.20.2009
Ironwood Pharmaceuticals Files Registration Statement for Initial Public Offering

11.10.2009
Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide

11.02.2009
Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials In Patients with Chronic Constipation

10.27.2009
Marsha Fanucci Joins Ironwood Board of Directors

View all releases »